21643-38-9

Usage

Uses

Used in Liquid Crystals Industry:
4-Hexylbenzoic acid is used as an intermediate for the synthesis of liquid crystals. Its chemical properties contribute to the development of liquid crystal materials with specific characteristics, such as improved stability, enhanced electro-optical properties, and better alignment capabilities. These liquid crystals are widely used in display technologies, including televisions, computer monitors, and smartphones.
Used in Chemical Synthesis:
4-Hexylbenzoic acid is also utilized as a building block in the synthesis of various organic compounds. Its versatile structure allows for further functionalization and modification, enabling the creation of new molecules with potential applications in pharmaceuticals, agrochemicals, and other specialty chemicals.
Used in Research and Development:
Due to its unique chemical properties, 4-Hexylbenzoic acid is often employed in research and development settings. Scientists and researchers use 4-Hexylbenzoic acid to study its reactivity, investigate its potential applications, and explore new methods for its synthesis and functionalization. This contributes to the advancement of knowledge in the field of organic chemistry and the development of new technologies and products.

InChI:InChI=1/C13H24O2/c1-2-3-4-5-6-11-7-9-12(10-8-11)13(14)15/h11-12H,2-10H2,1H3,(H,14,15)/p-1

Upstream product

• 49763-69-1 4-hexylbenzaldehyde 
• 124-38-9 carbon dioxide 
• 23703-22-2 1-bromo-4-n-hexylbenzene 
• 37592-72-6 1-(4-hexyl-phenyl)-ethanone 
• 50606-95-6 4-hexylbenzoyl chloride 
• 1077-16-3 hexylbenzene 
• 79-37-8 oxalyl dichloride 

Downstream Products

• 132668-24-7 2-(4-Hexyl-phenyl)-benzo[1,2-d;5,4-d']bisoxazole 
• 132668-26-9 2-Hexyl-6-(4-hexyl-phenyl)-benzo[1,2-d;5,4-d']bisoxazole 
• 132929-83-0 2,6-Bis-(4-hexyl-phenyl)-benzo[1,2-d;5,4-d']bisoxazole 
• 103177-39-5 8-(p-hexylbenzoyl)amino-2-(5-tetrazolyl)-4-oxo-4H-1-benzopyran 
• 103195-06-8 4-Hexyl-N-[3-(1H-tetrazol-5-yl)-2,3-dihydro-benzo[1,4]dioxin-5-yl]-benzamide 
• 50606-95-6 4-hexylbenzoyl chloride 
• 38289-30-4 trans-4-n-trans-cyclohexanecarboxylic acid 
• 67589-85-9 cis 4-n-hexylcyclohexanecarboxylic acid 
• 118578-88-4 4-hexylphenylmethyl alcohol 
• 132668-25-8 2-(4-Hexyl-phenyl)-6-pentyl-benzo[1,2-d;5,4-d']bisoxazole 
• 67589-91-7 trans-4-hexylcyclohexane-1-carboxylic acid chloride 
• 38454-36-3 4-Hexyl-benzoic acid 4-heptyloxy-phenyl ester 
• 38454-44-3 4-Hexyl-benzoic acid 4-butyl-phenyl ester 
• 38454-21-6 4-n-Hexylbenzoesaeure-<4'-butyloxyphenylester> 

Relevant academic research and scientific papers

Potentiation of the fosmidomycin analogue FR 900098 with substituted 2-oxazolines against Francisella novicida

A library of 33 compounds was screened for potentiation of the antibiotic FR 900098 against the Francisella tularensis surrogate Francisella novicida. From the screen a highly potent 2-oxazoline adjuvant was discovered capable of potentiating FR 900098 with a 1000-fold reduction in MIC against the Francisella sub-species F. novicida and F. philomiragia.

COMPOSITIONS AND METHODS FOR INHIBITING SPHINGOSINE KINASE

Amidine analogs that can inhibit the activity of sphingosine kinase 1 and sphingosine kinase 2 (SphK1 and SphK2) are provided. The compounds can prevent angiogenesis in tumor cells.

New potent antagonists of leukotrienes C4 and D4. 1. Synthesis and structure-activity relationships

(p-Amylcinnamoyl)anthranilic acid (3a) had moderate antagonist activities against LTD4-induced smooth muscle contraction on guinea pig ileum and LTC4-induced bronchoconstriction in anesthetized guinea pigs. Modifications were made in the hydrophobic part (cinnamoyl moiety) and the hydrophilic part (anthranilate moiety) of 3a. A series of 8-(benzoylamino)-2-tetrazol-5-yl-1,4-benzodioxans and 8-(benzoylamino)-2-tetrazol-5-yl-4-oxo-4H-1-benzopyrans were revealed to be potent antagonists of leukotrienes C4 and D4. Among both series, ONO-RS-347 (18k) and ONO-RS411 (19h) were the most potent and orally active antagonists, respectively. Structure-activity relationships are discussed.

Cyano-substituted biphenyl compounds and liquid crystalline dielectrics containing the same

Biphenyl derivatives of the formula: STR1 wherein X is --CO--O-- or --O--CO--, R1 and R4 are alkyl of 1 to 10 carbon atoms, and one of R2 and R3 is CN and the other is H, are useful for lowering the dielectric anisotropy of liquid crystalline dielectrics.